AJP - Endo Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 292: E1607-E1615, 2007. First published February 6, 2007; doi:10.1152/ajpendo.00512.2006
0193-1849/07 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/6/E1607    most recent
00512.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Puchowicz, M. A.
Right arrow Articles by LaManna, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Puchowicz, M. A.
Right arrow Articles by LaManna, J. C.

Diet-induced ketosis increases capillary density without altered blood flow in rat brain

Michelle A. Puchowicz, Kui Xu, Xiaoyan Sun, Andre Ivy, Doug Emancipator, and Joseph C. LaManna

Department of Anatomy, School of Medicine, Case Western Reserve University, Cleveland, Ohio

Submitted 21 September 2006 ; accepted in final form 31 January 2007


   ABSTRACT
TOP
 ABSTRACT
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
It is recognized that ketone bodies, such as R-beta-hydroxybutyrate (beta-HB) and acetoacetate, are energy sources for the brain. As with glucose metabolism, monocarboxylate uptake by the brain is dependent on the function and regulation of its own transporter system. We concurrently investigated ketone body influx, blood flow, and regulation of monocarboxylate transporter (MCT-1) and glucose transporter (GLUT-1) in diet-induced ketotic (KG) rat brain. Regional blood-to-brain beta-HB influx (µmol·g–1·min–1) increased 40-fold with ketosis (4.8 ± 1.8 plasmabeta-HB; mM) in all regions compared with the nonketotic groups (standard and no-fat diets); there were no changes in regional blood flow. Immunohistochemical staining revealed that GLUT-1 density (number/mm2) in the cortex was significantly elevated (40%) in the ketotic group compared with the standard and no-fat diet groups. MCT-1 was also markedly (3-fold) upregulated in the ketotic group compared with the standard diet group. In the standard diet group, 40% of the brain capillaries stained positive for MCT-1; this amount doubled with the ketotic diet. Western blot analysis of isolated microvessels from ketotic rat brain showed an eightfold increase in GLUT-1 and a threefold increase in MCT-1 compared with the standard diet group. These data suggest that diet-induced ketosis results in increased vascular density at the blood-brain barrier without changes in blood flow. The increase in extraction fraction and capillary density with increased plasma ketone bodies indicates a significant flux of substrates available for brain energy metabolism.

ketone bodies; monocarboxylate transporter-1; GLUT-1; beta-hydroxybutyrate; brain metabolism; blood-brain barrier

GLUCOSE IS THE MAJOR METABOLIC FUEL for the mammalian brain (37, 41), but alternate energy substrates such as ketone bodies, e.g., R-beta-hydroxybutyrate (beta-HB) and acetoacetate (6, 19, 29, 39), serve as efficient metabolic fuel sources for the brain. This is especially important under certain nutritional conditions, such as fasting, starvation (28), feeding of a high-fat diet (24, 26), and early development and throughout the suckling period (2, 25, 42). Clinicians and investigators have been interested in ketone bodies as therapeutic agents for the treatment of hypoglycemia, seizure disorders, and Alzheimer's and Parkinson's diseases and as alternatives to high-lipid parenteral and enteral feedings (5, 14, 43).

Similar in chemical structure to lactate and pyruvate (intermediates of glycolysis), ketones are metabolized by the brain, especially neonatal mammalian brain (1, 2, 20, 40). These short-chain acids are referred to as monocarboxylates, and, as with glucose metabolism, systemic delivery of these substrates and availability for neuronal uptake are highly dependent on their transport across the blood-brain barrier (BBB) through specific carrier-mediated facilitated transport processes. The first step to monocarboxylate entry at the BBB is through the monocarboxylate transporter (MCT-1) (3, 6, 42), which is the primary carrier-mediated transporter at the endothelial cell boundary of the BBB, analogous to the well-characterized transport system for D-glucose, GLUT-1 (7, 11, 31, 41).

Using the then-novel brain uptake index method, Oldendorf (27) was the first to describe the carrier-mediated BBB transport of short-chain monocarboxylate anions. Subsequent work in rats led to a modified uptake method, known as the single-pass dual-label isotope-indicator (unidirectional tracer) method, which allows for quantitation of substrates, such as glucose, lactate, or ketones, at the endothelial boundary of the BBB, as well as simultaneous estimation of blood flow (7, 16, 33).

MCT regulation in brain is dependent on nutritional status, especially during ketosis, such as that induced by diet (19), stage of development (6, 18, 42), and cell type (4, 8, 18, 23, 36, 42). MCT-1 and MCT-2 are known to play major functional roles in monocarboxylate metabolism in the brain in nonvascular and vascular regions. For example, MCT expression in rat brain has been associated with a role in the metabolic recovery following an ischemic insult (36, 45). However, the molecular and biochemical mechanisms underlying the regulation of MCT proteins in the brain, especially during a chronic state of ketosis, remain to be discerned.

It is unknown whether the influx of ketones across the BBB is related to changes in MCT-1 expression. The aim of this study was to assess MCT-1 transport capacity at the endothelial boundary of the BBB during chronic ketosis induced by diet. This study involved simultaneous measurement of the regional blood-to-brain ketone body uptake and blood flow across the BBB during elevated levels of blood ketones in a rat model of chronic ketosis. Using a single-pass dual-label isotope-indicator method, we measured blood-to-brain beta-HB influx and blood flow in cortical, hippocampal, cerebellar, and brain stem regions. To determine whether changes in beta-HB influx from blood to brain were a result of changes in blood flow and/or MCT protein expression, MCT-1 at the BBB was investigated under the condition of ketosis. The relation of MCT-1 to GLUT-1 was also studied by immunohistochemical analysis. This approach allowed for the concurrent assessment of changes in capillary density (10) and the coregulation of these two principal energy substrate transporters.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Animal preparation. All procedures were performed in strict accordance with the National Institutes of Health "Guide for the Care and Use of Laboratory Animals" and were approved by the Institutional Animal Care and Use Committee of Case Western Reserve University. Male Wistar rats (28 days old, 90–130 g body wt) were allowed to acclimate in the Case Western Reserve University animal facility for 1 wk before they were used in experiments. Rats were then assigned randomly to three groups fed ad libitum for 4–6 wk as follows: the KG group was fed a ketogenic (high-fat, no-carbohydrate) diet, the CHO group was fed a high-carbohydrate, low-fat diet, and the STD group was fed standard laboratory chow (Table 1). The traditional (STD) diet (no. 8664, Teklab) was used as a control to the KG diet, and the CHO diet was used as an additional control to match micronutrient and protein components of the KG diet [diet nos. D12359 [GenBank] (CHO) and D12369b (KG), Research Diets, New Brunswick, NJ; info@ResearchDiets.com]. Before feeding was initiated, all the rats were fasted for 24 h to deplete glucose stores and initiate a state of ketosis.


View this table:
[in this window]
[in a new window]

  		Table 1. Diet compositions

 
Surgical procedures. On the day of the beta-HB influx and blood flow experiments, nonfasted rats were anesthetized with 4% chloral hydrate (10 ml/kg ip; Fisher Scientific, Fair Lawn, NJ) during the surgical preparation and for the duration of the experiment, as previously described (17). Use of nonvolatile anesthesia enabled us to compare results with our previous measurements of regional blood flow in rat brain. Briefly, the surgical procedure involved placement of a right atrial silicone catheter (0.025 in. ID, 0.047 in. OD) into the external jugular vein and its insertion into the right atrium. A second polyethylene (PE-50) catheter (0.023 in. ID, 0.038 in. OD) was placed in the femoral artery to monitor arterial blood pressure and obtain blood samples for blood gases [pH, arterial PCO2 (PaCO2), and arterial PO2], hematocrit, radioisotope tracer content, and plasma substrate concentrations of glucose, lactate, and ketones (beta-HB). Rectal temperature was monitored and maintained at ~37°C by a feedback-controlled infrared lamp.

Measurement of blood substrate contents. Plasma samples from rats used for the beta-HB influx and blood flow experiments were analyzed for glucose, lactate, and ketones (beta-HB) by standard enzymatic assays on a Cobas Faras centrifuge analyzer-spectrophotometry system (Roche). In the rats used for immunohistochemical and immunocytochemical analyses, a small blood sample taken by tail stick from the KG group at week 3 and on the final day just before collection of brain tissue was tested using a MediSense Precision Xtra ketone meter (Abbott Laboratories, Bedford, MA) to ensure blood ketosis (beta-HB) levels >1.0 mM (33).

Regional blood-to-brain beta-HB influx and blood flow calculations. The single-pass dual-label isotope-indicator method was used to simultaneously measure regional beta-HB influx and blood flow in the brain (17, 34) in the STD (n = 7), CHO (n = 6), and KG (n = 13) groups. The femoral artery cannula was connected to a syringe pump calibrated to withdraw blood at a rate of 1.60 ml/min and started 3 s before administration of the tracers. A bolus containing the radioisotopes n-[3H]butanol (1.0 Ci/mol; American Radiolabeled Chemicals, St. Louis, MO) and D-[14C]beta-HB (1.0 Ci/mol; New England Nuclear, Boston, MA) was given via jugular vein catheter 12 s before the animals were decapitated. The withdrawn blood was collected quantitatively into preweighed vials, and the radioisotope content of the aliquots was measured. To correct for the residual vascular radioactive content, samples of venous blood oozing from the foramen magnum were collected at decapitation in heparinized tubes, and aliquots of the venous plasma were counted to estimate the intravascular compartment volumes (17). Brains were rapidly removed, bilateral regional (frontal, parietal, hippocampal, cerebellum, and brain stem) samples were weighed and solubilized in tightly closed scintillation vials, and radioisotope content was determined by beta-scintillation spectroscopy (model 1600 TR, Packard Instrument, Downers Grove, IL).

Regional blood-to-brain beta-HB influx and blood flow calculations. Blood flow (BF; ml·g–1·min–1) and beta-HB influx (J; µmol·g–1·min–1) were determined from the measured radioisotope contents in each of the brain tissue and blood samples as follows (17)

Formula

Formula
where Fs is the syringe withdrawal rate (ml/min), Fpl is plasma flow [BF x (1 – Hct)], [beta-HBpl] is plasma beta-HB concentration (mM), and E is the extraction fraction, i.e., ratio of tracer in tissue to tracer in arterial blood [(14C/3H)tissue/(14C/3H)art]. Disintegrations per minute (dpm) in brain tissue samples were corrected (dpmcorrect) for intravascular compartment volumes (Vpl) as follows: dpmcorrect = dpmtissue – (dpmpl/µl x Vpl x tissue wt) (16).

Immunohistochemistry. Since all capillaries highly stain for GLUT-1, indicative of the GLUT-1 transporter as a marker of the BBB changes in capillary density, rat brains were analyzed for cortical capillary density using immunohistochemical staining for GLUT-1 (STD, CHO, and KG groups, n = 4 per group), as previously described (10, 32). The protein expression of MCT-1 in capillaries at the BBB was also determined using immunohistochemistry. Briefly, rats were deeply anesthetized and transcardially perfused with PBS (pH 7.4) and then with 4% paraformaldehyde. Brains were removed and embedded in paraffin. The coronal-cortical serial sections (5 µm, average of 3 sections, over 200 µm area per animal) were made from the full depth of the frontal cortex (beginning at bregma 1.6 mm, approximately plates 12–16, Paxinos-Watson stereotaxic coordinates), deparaffinized, rehydrated, and subjected to antigen retrieval in a microwave oven for 10 min using 0.01 M sodium citrate buffer (pH 6.0; Sigma). Endogenous peroxidase activity was blocked with 1% H2O2 in methanol for 10 min.

Sections were washed with PBS, incubated with 10% normal serum for 1 h, and incubated overnight at 4°C with a chicken anti-MCT-1 polyclonal antibody raised against the COOH-terminal 15 amino acids (1:300 dilution; Chemicon) or goat anti-GLUT-1 polyclonal antibody raised against a peptide mapping within the COOH terminus (1:200 dilution; Santa Cruz Biotechnology). Subsequently, they were incubated with biotinylated anti-chicken IgG or anti-goat IgG antibody (1:200 dilution; Vector Laboratories) and ABC complex solution (Vectastain ABC Kit, Vector Laboratories). Sections were developed in diaminobenzidine and H2O2 solution for color detection. Images of full-depth cortical sections were digitized with a SPOT digital camera connected to a Nikon E600 Eclipse microscope with x200 magnification. A computer image analysis system (Image Pro Plus, San Diego, CA) was used to detect MCT-1- and GLUT-1-positive staining, and microvessel (capillary) profiles were quantified by an experimentally blinded observer and expressed as number per square millimeter (15).

Colocalization of MCT-1 to GLUT-1 was assessed by double immunocytochemical labeling for MCT-1 and GLUT-1 to analyze immunoreactivities of the cortical sections. Sections were dewaxed, rehydrated, washed in PBS, and subjected to antigen retrieval. Slides were blocked with 10% normal donkey serum for 1 h at room temperature. Then the sections were treated with a mixture of the two primary antibodies, chicken anti-MCT-1 polyclonal antibody (1:300 dilution) and goat anti-GLUT-1 polyclonal antibody (1:200 dilution; Santa Cruz Biotechnology), overnight at 4°C. The sections were washed and incubated with fluorescein-conjugated secondary antibody solution (Jackson ImmunoResearch Laboratories), which consisted of FITC-conjugated anti-chicken IgY (IgG) antibody (1:150 dilution) for MCT-1 (green) and Cy3-conjugated anti-goat IgG antibody (1:200 dilution) for GLUT-1 (red), for 1 h. Slides were rinsed and immediately mounted with Vectashield mounting medium (Vector Laboratories). Green and red light wavelengths were used to observe the stained sections, and the images were obtained with a SPOT digital camera connected to a Nikon E600 Eclipse microscope with x400 magnification.

Isolation of brain microvessels. Rat microvessels from the cerebral cortex (STD, CHO, and KG groups, n = 4) were isolated using a method previously described, with slight modifications (38). Briefly, after the animals were decapitated, the brains were quickly removed, and the cortical mantles were homogenized in 10 vol of ice-cold microvessel buffer (MB; 15 mM HEPES, 147 mM NaCl, 4 mM KCl, 3 mM CaCl2, 12 mM MgCl2, 5 mM glucose, and 0.5% BSA) supplemented with a protease inhibitor cocktail tablet (Roche Applied Science). The homogenates were centrifuged at 900 g for 10 min at 4°C, and the pellets were resuspended and separated by centrifugation through 17% dextran-MB. The vessels were resuspended in MB and filtered through a 125-µm and then a 40-µm nylon mesh. After elution from the 40-µm mesh with BSA-free MB, microvessels were pelleted, washed several times, resuspended in lysis buffer [50 mM Tris·HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1% Triton X-100 0.1% SDS, 1% sodium deoxycholate, 1.0 mM Na3VO4, and a protease inhibitor cocktail tablet (Roche Applied Science)], and stored at –80°C for Western blot analysis.

Western blot analysis. MCT-1 and GLUT-1 protein contents in freshly isolated cortical microvessels were analyzed by Western blot in each of the diet groups. Microvessel samples (25 µg of protein) were separated on 10% SDS-polyacryamide gels and transferred to nitrocellulose membrane. The membrane was blocked with 5% nonfat milk in TBS + Tween 20. Blots were incubated overnight at 4°C with anti-MCT-1 (1:500 dilution; Chemicon) and anti-GLUT-1 (1:200 dilution; Santa Cruz Biotechnology) and then with an appropriate horseradish peroxidase-conjugated secondary antibody. Detection was performed through enhanced chemiluminescence reaction (Amersham Biosciences). Western blots were subsequently scanned and quantified by densitometry using Sigmascan Pro (Sigma).

Statistical analysis. Values are means (SD). Group comparisons were analyzed by one-way ANOVA with Tukey's correction method, unpaired t-test, and multivariate linear model (SPSS/PC version 13.0). P < 0.05 was considered statistically significant. In the blood flow and beta-HB influx experiments, measurements of the cortical (frontal and parietal), hippocampal, cerebellar, and brain stem regions were the averages of the bilateral regions (inasmuch as there were no significant differences between the left and right regions).


   RESULTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 GRANTS
 REFERENCES
 
Effect of ketosis on plasma beta-HB concentration. Plasma beta-HB was significantly elevated in the KG group compared with the STD and CHO groups. Plasma beta-HB concentration was elevated ~24-fold in the KG group compared with the nonketotic (STD and CHO) groups (Table 2). Plasma glucose and lactate concentrations were not significantly different among the diet groups.


View this table:
[in this window]
[in a new window]

  		Table 2. Physiological parameters

 
The diet conditions did not affect the physiological parameters pH, PaCO2, arterial PO2, hematocrit, mean blood pressure, and body weight, except in the KG group, where PaCO2 was slightly, but significantly, lower than in the other two diet groups (Table 2). This change in PaCO2 was most likely not physiologically significant, since the arterial blood pH remained within normal limits. All rats in each of the groups gained weight consistently over the experimental period. Weight gain was less in the KG group than in the other two groups, but there were no significant differences among diet groups. The physiological data were similar to those we previously reported in chloral hydrate-anesthetized rats (16, 17, 35).

beta-HB influx and extraction fraction. Regional blood-to-brain beta-HB influx (µmol·g–1·min–1) was ~40-fold greater in all regions in the KG group than in the nonketotic groups (Fig. 1A). In the KG group, the average cortical influx was 0.45 (SD 0.07) (n = 13), whereas influx in the hippocampal, cerebellar, and brain stem regions [0.38 (SD 0.10), 0.42 (SD 0.07), and 0.35 (SD 0.07), respectively] was slightly lower than, but not significantly different from, that in the cortex. The regional variations in beta-HB influx were greater in the KG group than in the CHO and STD groups, reflective of the wide range of ketosis at plasma beta-HB concentrations of 1.4–8.3 mM. Within each dietary group, there were no differences in regional beta-HB influxes.


Figure 1
View larger version (10K):
[in this window]
[in a new window]

  		Fig. 1. Regional brain ketone body influx in rats fed standard laboratory chow (STD, n = 7), high-carbohydrate, low-fat (CHO, n = 6), or ketogenic, high-fat, no-carbohydrate (KG, n = 13) diet. A: ketone [beta-hydroxybutyrate (beta-HB)] influx was significantly elevated in all regions [frontal, parietal, hippocampal, cerebellar, and brain stem (BrStem)] in the KG group compared with the nonketotic (STD and CHO) groups. There were no regional differences within diet groups. B: cortical (frontal + parietal) beta-HB influx as a function of plasma beta-HB concentration. Influx increased with increasing plasma beta-HB concentration (1.4–8.3 mM). Values are means (SD). *P < 0.05 vs. STD and CHO (by ANOVA).

 
Since influx (see equation in MATERIALS AND METHODS) is a function of plasma beta-HB concentration, we assessed the beta-HB transport profile in the cortex of the KG group. Figure 1B shows a nonlinear, Michaelis-Menten-type relation of beta-HB influx in the cortex as a function of plasma beta-HB concentration; influx correlated (R2 = 0.8) with plasma beta-HB concentration (1.4–8.3 mM), at a ratio of ~10:1. Thus, for every 1.0 mM plasma beta-HB, there was an influx of 0.1 µmol·g–1·min–1 from blood to brain. This relation was similar in other regions (data not shown). The diffusional component was not determined in this study, inasmuch as it requires a nonstereospecific substrate, and little is known about the stereospecificity of MCT and ketones (e.g., S-beta-HB) in the brain.

Regional brain extraction fractions in each of the diet groups are shown in Fig. 2. Extraction of beta-HB from blood to brain at the BBB in all regions of the brain was greater in the KG group than in the nonketotic groups. There was a significant (~50%) increase in beta-HB transport from blood to brain in the cortical regions (frontal and parietal) and an ~30% increase in the hippocampal region in the KG group compared with the STD and CHO groups. There were no significant differences in regional extraction fractions between the STD and the CHO group. Comparison of the regional averages of all three diet groups showed a significantly lower extraction fraction in the brain stem than in the cerebellar region, but not in the other brain regions.


Figure 2
View larger version (12K):
[in this window]
[in a new window]

  		Fig. 2. Regional ketone body extraction fraction in brain (14C-to-3H ratio in tissue vs. blood) in KG, STD, and CHO groups. Extraction fraction of beta-HB was greatest in the KG group in all regions (cortical, hippocampal, cerebellar, and brain stem). Frontal and parietal extractions were significantly elevated in the KG group compared with the STD and CHO groups. Values are means (SD). *Significantly different from STD and CHO; {ddagger}significantly different from cerebellar (P < 0.05).

 
Regional brain blood flow. Regional brain blood flows (ml·g–1·min–1) in each of the diet groups are shown in Fig. 3. Diet composition (STD, CHO, or KG) did not affect regional blood flows, inasmuch as there was no significant difference among the regions. The trends in regional blood flows in the STD group showed that blood flow was highest in the cortex [1.1 (SD 0.1)] and brain stem (1.4 ± 0.2) and lowest in the cerebellum [0.90 (SD 0.2)]. Regional blood flows measured in this study were comparable to those previously reported using the blood flow-indicator method (16, 17, 35, 44).


Figure 3
View larger version (14K):
[in this window]
[in a new window]

  		Fig. 3. Regional brain blood flow in KG, STD, and CHO groups. Blood flows were measured at beta-HB plasma concentrations (mM) of 0.16 (SD 0.02), 0.24 (SD 0.2), and 4.8 (SD 1.8) in STD, CHO, and KG groups, respectively (see Table 2). Diet composition did not affect regional blood flows. Blood flows were lowest in the cerebellar region. Values are means (SD). *Significantly different from frontal and parietal; {ddagger}significantly different from brain stem (P < 0.05).

 
MCT-1 immunoreactivity and capillary density profiles. MCT-1 and GLUT-1 immunohistochemical staining was visible in coronal-cortical sections from brains of rats fed the three diets (Fig. 4A). MCT-1 immunoreactivity profiles and cerebral capillary density (identified by GLUT-1 immunostaining) were determined from the number of positive counts per unit area (number/mm2; Fig. 4B). MCT-1 staining appeared to predominate in the microvessels, as previously described (4, 6), with the greatest number of positive counts for MCT-1 in the KG group (Fig. 4). MCT-1 increased threefold in the KG group compared with the STD group: 428.7 (SD 36.8) vs. 138.4 (SD 10.4) (Fig. 4B). Capillary density (as shown by GLUT-1 staining) increased 40% in the KG group compared with the STD group (Fig. 4B). The capillary density profile in the STD group was similar to that previously reported (9, 32). Immunoreactivity was similar for GLUT-1 and MCT-1 in the CHO and STD groups.


Figure 4
View larger version (59K):
[in this window]
[in a new window]

  		Fig. 4. Monocarboxylate transporter-1 (MCT-1) and GLUT-1 immunoreactivities in coronal-cortical sections in KG, STD, and CHO groups. A: MCT-1 and GLUT-1 immunohistochemical staining was visible in all groups. For MCT-1 and GLUT-1, intensity was greatest in the KG group. Increased intensity of GLUT-1 staining in the KG group indicates increased cortical capillary density. Images are representative of results from 4 observations. B: MCT-1 and GLUT-1 density analyses from coronal-cortical sections in A. Positive staining is expressed as number/mm2. MCT-1 immunoreactivity was 3-fold greater in the KG group than in the STD and CHO groups. Capillary density (as measured by GLUT-1 staining) increased by 40% in the KG group compared with the STD and CHO groups. Ratio of MCT-1 to GLUT-1 increased (1:1) in the KG group. Values are means (SD). *P < 0.05 vs. STD and CHO.

 
MCT-1 and GLUT-1 expression in isolated microvessels. Changes in MCT-1 and GLUT-1 protein content at the BBB were further assessed by Western blot analysis of isolated microvessels, which revealed a threefold increase in MCT-1 and an eightfold increase in GLUT-1 in the KG group compared with the STD group (Fig. 5). Although expression was not as prevalent as in the KG group, the CHO group also showed an upward trend in these proteins in the isolated microvessels compared with the STD group that was not evident by immunoreactive staining.


Figure 5
View larger version (19K):
[in this window]
[in a new window]

  		Fig. 5. Immunoblots of MCT-1 and GLUT-1 in isolated microvessels from STD, CHO, and KG groups. A: Western blot showing induction of MCT-1 and GLUT-1 in the KG group compared with the STD and CHO groups. Blots are representative of results from 4 similar observations. B: MCT-1 and GLUT-1 density analyses (%change in protein-to-actin optical density ratio) showed a 3-fold increase in MCT-1 and an 8-fold increase in GLUT-1 in the KG group compared with the STD group. Values are means (SD). *P < 0.05 vs. GLUT-1 in STD. {ddagger}P < 0.05 vs. MCT-1 in STD.

 
Colocalization of MCT-1 and GLUT-1. Labeling of MCT-1 (green) and GLUT-1 (red) was observed in all diet groups, with the greatest immunoreactivities for MCT and GLUT in the KG group (Fig. 6). Since there were no observable differences between the CHO and the STD group, data for the CHO group are not shown. Colocalization of MCT-1 and GLUT-1 was increased in the KG group, as indicated by the yellow immunofluorescence, compared with the STD group. These data are consistent with the results in Fig. 5, which shows an increase in the number of capillaries, as well as in the ratio of MCT-1 to GLUT-1.


Figure 6
View larger version (34K):
[in this window]
[in a new window]

  		Fig. 6. MCT-1 and GLUT-1 immunofluorescent staining in coronal-cortical sections of STD and KG groups (data for the CHO group are not different from data for the STD group). MCT-1 (green) and GLUT-1 (red) immunofluorescent staining was greater in the KG than in the STD group. Colocalization of MCT-1 and GLUT-1 was detected by yellow immunofluorescence in all brains, with greater concentration in the KG than in the STD group.

 

   DISCUSSION
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
GRANTS
 REFERENCES
 
Chronic ketosis in rats induced by a KG diet resulted in a 20-fold increase in plasma beta-HB. These levels were similar to those in humans fed a KG diet or fasted for 3 days. The increase in beta-HB levels was associated with a 40-fold increase in beta-HB brain influx and an increase in brain capillary density (measured by GLUT-1 immunostaining) without changes in regional blood flow or plasma glucose levels. Brain capillary MCT-1 also increased relative to the capillary density and content measured in the STD group.

Since ketone body influx into the brain is largely dependent on the blood concentration of ketones (12, 26, 29) and the activity of the MCT system (6), we expected that an increase in plasma beta-HB concentration would result in increased beta-HB influx across the BBB. A significant increase in plasma beta-HB concentrations, as well as an increase in beta-HB uptake in the brain, was observed. beta-HB uptake in our adult ketotic rat model was consistent with brain ketone uptake with increased plasma ketone levels in humans (26, 29).

Similar to our findings, in an MR spectroscopy study, a 20-fold increase in brain beta-HB levels in 3-day-fasted vs. nonfasted status correlated with the increase in plasma beta-HB (mM) (29), suggesting that adaptation begins as early as 3 days of ketosis. Our results, together with others, suggest that the level and duration of ketosis regulate the protein expression of MCT-1 at the BBB and that a doubling of the beta-HB extraction fraction relative to plasma beta-HB concentration appears to be reflective of the upregulation in MCT-1.

Although altered blood flow associated with ketosis has been reported in some models (13, 21), this was not the case in our rat study. The increase in beta-HB influx across the BBB was not a result of changes in blood flow. Regional brain blood flows measured in this study were comparable to those previously reported using the blood flow-indicator method (16, 17, 35, 44). These inconsistencies may be partly due to the process (acute vs. chronic) by which ketosis is induced, such as diet, fasting, or exogenous administration of ketones.

In an acute PET study of hyperketonemia (blood ketones 2.2 mM) in humans, global blood flow was reported to increase 39% relative to baseline (before ketone body infusion) with a fivefold increase in ketone uptake by brain and an equivalent reduction in glucose metabolism, reflecting the immediate uptake of ketones at the BBB and utilization by the brain (13). These results suggest that the increase in beta-HB uptake is most likely related to the increase in blood ketones, as well as increased delivery (via increased blood flow). On the basis of our data [40-fold increase in influx with a 20-fold increase in plasma beta-HB (4.0 mM)], blood ketone levels of 2.2 mM would predict a 10-fold increase in beta-HB blood-to-brain influx, rather than a 5-fold increase, as reported in the human study. A twofold difference (5 vs. 10) may be the result of the lack of upregulation of MCT at the BBB in an acute condition, suggesting that an adaptive process occurs with chronic ketosis, such as that induced by diet.

To further explore whether the increase in beta-HB influx was reflective of the upregulation in MCT-1, the functional role of MCT regulation at the BBB was evaluated. First, the evaluation was based on the idea that the extraction fraction is more of a functional measure of absolute beta-HB influx at the BBB, inasmuch as it is not dependent on the beta-HB plasma concentration or syringe withdrawal rate. It is the ratio of tracers in the brain to the periphery and, thus, is more reflective of the fractional changes in influx of beta-HB at the BBB, which is indicative of the changes in transporter protein regulation. Our data show that the cortical extraction fraction of beta-HB in the KG group reached about twice that of the STD group. Second, using immunohistochemical and Western blot analyses, we measured MCT-1 protein regulation at the BBB and found consistently a threefold induction in the capillaries compared with the STD group. Thus the increase in extraction fraction as a result of ketosis corresponds with the increase in MCT-1 at the BBB. These results support the hypothesis that the increase in MCT-1 is functional.

An upregulation of MCT-1 is thought to reflect the brain's reliance on ketones as an alternate energy substrate to glucose (4, 6, 18, 19, 23, 42). In support of these findings, such characteristics would be advantageous to ensure continuous delivery of energy substrate to the brain during glucose sparing, such as with fasting or starvation or when the dietary primary fuel source is derived from fat, e.g., a KG diet. The significant increase regional beta-HB influx with no changes in blood flow or plasma glucose levels suggests that ketone bodies are made more readily available to brain for oxidation, especially to regions with high metabolic rates. This would be critical during an energy deficit or a metabolic crisis.

The 40% increase in cortical capillary density observed with ketosis and the threefold increase in the fraction of capillaries that stained for MCT-1 suggest that a significant amount of ketone bodies are made available for brain metabolism. The colocalization of MCT-1 and GLUT-1 indicates that MCT-1 is localized to the microvessels. The increased colocalization of MCT-1 and GLUT-1 in the KG group also reflects the increased availability of ketones (23), but the fraction of ketones consumed for ATP production remains unknown.

Ketone body utilization in adult ketotic rat brain may account for >6% of cerebral metabolic rate of O2. We estimated that ~35% of ATP production could come from the oxidation of ketones that are made available through its transport. Assuming the complete oxidation of beta-HB and glucose, we based our estimate on the measured beta-HB influx (0.4 µmol·g–1·min–1) and the influx for glucose (0.8 µmol·g–1·min–1), as previously reported (16). This is similar to beta-HB and glucose influx projected for humans under chronic conditions of ketosis. In addition, in the KG group, the increase in GLUT-1 content measured in microvessels was three times greater than that measured in brain slices. These results suggest that the upregulation of GLUT-1 also occurred along the capillary.

The establishment of new microvascular patterns through angiogenic response to ketosis in rat brain is similar to hypoxia-induced angiogenesis (15). The link between angiogenesis and ketosis in unknown and was unexpected. One explanation may be elevated tissue levels of hypoxia inducible factor-1{alpha}, a transcription factor that mediates adaptive responses to hypoxia (unpublished data). Ketones, such as beta-HB, may act as metabolic regulators related to the stabilization of hypoxia inducible factor-1{alpha} under normoxic conditions (22).

In conclusion, maintenance of rats on the KG diet results in a physiologically meaningful increase in plasma beta-HB. This increase in plasma ketone bodies, together with the increase in extraction fraction and capillary density, indicates that a significant flux of substrates (reducing equivalents) is available for brain energy metabolism. Increased ketone availability, even in the presence of adequate glucose availability, leads to an upregulation of MCT-1 and an increase in beta-HB influx. Whether there is an increase in net flux (ketone consumption for ATP production) with a decrease in glucose consumption remains to be determined.


   GRANTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
REFERENCES
 
These studies were supported by National Institutes of Health Grants NS-46074 and GM-066309.


   ACKNOWLEDGMENTS
 
We thank Constantinos P. Tsipis for technical efforts.


   FOOTNOTES
 

Address for reprint requests and other correspondence: M. A. Puchowicz, Dept. of Anatomy, Case Western Reserve Univ., School of Medicine, 10900 Euclid Ave., Cleveland, OH 44106-4938 (e-mail: map10{at}case.edu)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


   REFERENCES
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Cremer JE, Cunningham VJ, Pardridge WM, Braun LD, Oldendorf WH. Kinetics of blood-brain barrier transport of pyruvate, lactate and glucose in suckling, weanling and adult rats. J Neurochem 33: 439–445, 1979.[ISI][Medline]
  2. Dombrowski GJ Jr, Swiatek KR, Chao KL. Lactate, 3-hydroxybutyrate, and glucose as substrates for the early postnatal rat brain. Neurochem Res 14: 667–675, 1989.[CrossRef][ISI][Medline]
  3. Enerson BE, Drewes LR. Molecular features, regulation, and function of monocarboxylate transporters: implications for drug delivery. J Pharm Sci 92: 1531–1544, 2003.[CrossRef][ISI][Medline]
  4. Fayol L, Baud O, Monier A, Pellerin L, Magistretti P, Evrard P, Verney C. Immunocytochemical expression of monocarboxylate transporters in the human visual cortex at midgestation. Brain Res Dev Brain Res 148: 69–76, 2004.[CrossRef][Medline]
  5. Freeman JM, Vining EPG, Pillas DJ, Pyzik PL, Casey JC, Kelly MT. The efficacy of the ketogenic diet—1998: a prospective evaluation of intervention in 150 children. Pediatrics 102: 1358–1363, 1998.[Abstract/Free Full Text]
  6. Gerhart DZ, Enerson BE, Zhdankina OY, Leino RL, Drewes LR. Expression of monocarboxylate transporter MCT1 by brain endothelium and glia in adult and suckling rats. Am J Physiol Endocrinol Metab 273: E207–E213, 1997.[Abstract/Free Full Text]
  7. Gjedde A. Modulation of substrate transport to the brain. Acta Neurol Scand 67: 3–25, 1983.[ISI][Medline]
  8. Hanu R, McKenna M, O'Neill A, Resneck WG, Bloch RJ. Monocarboxylic acid transporters, MCT1 and MCT2, in cortical astrocytes in vitro and in vivo. Am J Physiol Cell Physiol 278: C921–C930, 2000.[Abstract/Free Full Text]
  9. Harik N, Harik SI, Kuo NT, Sakai K, Przybylski RJ, LaManna JC. Time course and reversibility of the hypoxia-induced alterations in cerebral vascularity and cerebral capillary glucose transporter density. Brain Res 737: 335–338, 1996.[CrossRef][ISI][Medline]
  10. Harik SI, Kalaria RN, Andersson L, Lundahl P, Perry G. Immunocytochemical localization of the erythroid glucose transporter: abundance in tissues with barrier functions. J Neurosci 10: 3862–3872, 1990.[Abstract]
  11. Harik SI, LaManna JC. Vascular perfusion and blood-brain glucose transport in acute and chronic hyperglycemia. J Neurochem 51: 1924–1929, 1988.[CrossRef][ISI][Medline]
  12. Hasselbalch SG, Knudsen GM, Jakobsen J, Hageman LP, Holm S, Paulson OB. Blood-brain barrier permeability of glucose and ketone bodies during short-term starvation in humans. Am J Physiol Endocrinol Metab 268: E1161–E1166, 1995.[Abstract/Free Full Text]
  13. Hasselbalch SG, Madsen PL, Hageman LP, Olsen KS, Justesen N, Holm S, Paulson OB. Changes in cerebral blood flow and carbohydrate metabolism during acute hyperketonemia. Am J Physiol Endocrinol Metab 270: E746–E751, 1996.[Abstract/Free Full Text]
  14. Kashiwaya Y, Takeshima T, Mori N, Nakashima K, Clarke K, Veech RL. D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. Proc Natl Acad Sci USA 97: 5440–5444, 2000.[Abstract/Free Full Text]
  15. LaManna JC, Chavez JC, Pichiule P. Structural and functional adaptation to hypoxia in the rat brain. J Exp Biol 207: 3163–3169, 2004.[Abstract/Free Full Text]
  16. LaManna JC, Harik SI. Regional studies of blood-brain barrier transport of glucose and leucine in awake and anesthetized rats. J Cereb Blood Flow Metab 6: 717–723, 1986.[ISI][Medline]
  17. LaManna JC, Harrington JF, Vendel LM, Abi-Saleh K, Lust WD, Harik SI. Regional blood-brain lactate influx. Brain Res 614: 164–170, 1993.[CrossRef][ISI][Medline]
  18. Leino RL, Gerhart DZ, Drewes LR. Monocarboxylate transporter (MCT1) abundance in brains of suckling and adult rats: a quantitative electron microscopic immunogold study. Brain Res Dev Brain Res 113: 47–54, 1999.[Medline]
  19. Leino RL, Gerhart DZ, Duelli R, Enerson BE, Drewes LR. Diet-induced ketosis increases monocarboxylate transporter (MCT1) levels in rat brain. Neurochem Int 38: 519–527, 2001.[CrossRef][ISI][Medline]
  20. Levitsky LL, Fisher DE, Paton JB, Delannoy CW. Fasting plasma levels of glucose, acetoacetate, D-beta-hydroxybutyrate, glycerol, and lactate in the baboon infant: correlation with cerebral uptake of substrates and oxygen. Pediatr Res 11: 298–302, 1977.[ISI][Medline]
  21. Linde R, Hasselbalch SG, Topp S, Paulson OB, Madsen PL. Global cerebral blood flow and metabolism during acute hyperketonemia in the awake and anesthetized rat. J Cereb Blood Flow Metab 26: 170–180, 2006.[CrossRef][ISI][Medline]
  22. Lu H, Forbes RA, Verma A. Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem 277: 23111–23115, 2002.[Abstract/Free Full Text]
  23. Maurer MH, Canis M, Kuschinsky W, Duelli R. Correlation between local monocarboxylate transporter 1 (MCT1) and glucose transporter 1 (GLUT1) densities in the adult rat brain. Neurosci Lett 355: 105–108, 2004.[CrossRef][ISI][Medline]
  24. Nebeling LC, Lerner E. Implementing a ketogenic diet based on medium-chain triglyceride oil in pediatric patients with cancer. J Am Diet Assoc 95: 693–697, 1995.[CrossRef][ISI][Medline]
  25. Nehlig A, Pereira d V. Glucose and ketone body utilization by the brain of neonatal rats. Prog Neurobiol 40: 163–221, 1993.[CrossRef][ISI][Medline]
  26. Novotny EJ, Rothman DL. Observation of cerebral ketone bodies by 1H MR spectroscopy. Ann Neurol 40: 285, 1996.[CrossRef]
  27. Oldendorf WH. Carrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids. Am J Physiol 224: 1450–1453, 1973.[Free Full Text]
  28. Owen OE, Morgan AP, Kemp HG, Sullivan JM, Herrera MG, Cahill GF Jr. Brain metabolism during fasting. J Clin Invest 46: 1589–1595, 1967.[ISI][Medline]
  29. Pan JW, Rothman TL, Behar KL, Stein DT, Hetherington HP. Human brain beta-hydroxybutyrate and lactate increase in fasting-induced ketosis. J Cereb Blood Flow Metab 20: 1502–1507, 2000.[CrossRef][ISI][Medline]
  30. Pelligrino DA, LaManna JC, Duckrow RB, Bryan RM Jr, Harik SI. Hyperglycemia and blood-brain barrier glucose transport. J Cereb Blood Flow Metab 12: 887–899, 1992.[ISI][Medline]
  31. Pichiule P, Chavez JC, Xu K, LaManna JC. Angiopoietin-2 and rat brain capillary remodeling during adaptation and deadaptation to prolonged mild hypoxia. J Appl Physiol 93: 1131–1139, 2002.[Abstract/Free Full Text]
  32. Puchowicz MA, Emancipator DS, Xu K, Magness DL, Ndubuizu OI, Lust WD, LaManna JC. Adaptation to chronic hypoxia during diet-induced ketosis. Adv Exp Med Biol 566: 51–57, 2005.[ISI][Medline]
  33. Puchowicz MA, Xu K, LaManna JC. Single-pass dual-label indicator method. Blood-to-brain transport of glucose and short-chain monocarboxylic acids. Methods Mol Med 89: 265–276, 2003.[Medline]
  34. Puchowicz MA, Xu K, Magness D, Miller C, Lust WD, Kern TS, LaManna JC. Comparison of glucose influx and blood flow in retina and brain of diabetic rats. J Cereb Blood Flow Metab 24: 449–457, 2004.[CrossRef][ISI][Medline]
  35. Schurr A, Payne RS, Miller JJ, Tseng MT, Rigor BM. Blockade of lactate transport exacerbates delayed neuronal damage in a rat model of cerebral ischemia. Brain Res 895: 268–272, 2001.[CrossRef][ISI][Medline]
  36. Siesjo BK. In: Brain Energy Metabolism. New York: Wiley, 1978, p. 101–125.
  37. Simpson IA, Appel NM, Hokari M, Oki J, Holman GD, Maher F, Koehler-Stec EM, Vannucci SJ, Smith QR. Blood-brain barrier glucose transporter: effects of hypo- and hyperglycemia revisited. J Neurochem 72: 238–247, 1999.[CrossRef][ISI][Medline]
  38. Sokoloff L. Metabolism of ketone bodies by the brain. Annu Rev Med 24: 271–280, 1973.[CrossRef][ISI]
  39. Vannucci RC, Duffy TE. Carbohydrate metabolism in fetal and neonatal rat brain during anoxia and recovery. Am J Physiol 230: 1269–1275, 1976.[Abstract/Free Full Text]
  40. Vannucci SJ, Clark RR, Koehler Stec E, Li K, Smith CB, Davies P, Maher F, Simpson IA. Glucose transporter expression in brain: relationship to cerebral glucose utilization. Dev Neurosci 20: 369–379, 1998.[CrossRef][ISI][Medline]
  41. Vannucci SJ, Simpson IA. Developmental switch in brain nutrient transporter expression in the rat. Am J Physiol Endocrinol Metab 285: E1127–E1134, 2003.[Abstract/Free Full Text]
  42. Veech RL, Chance B, Kashiwaya Y, Lardy HA, Cahill GF Jr. Ketone bodies, potential therapeutic uses. IUBMB Life 51: 241–247, 2001.[ISI][Medline]
  43. Xu K, Puchowicz MA, LaManna JC. Renormalization of regional brain blood flow during prolonged mild hypoxic exposure in rats. Brain Res 1027: 188–191, 2004.[CrossRef][ISI][Medline]
  44. Zhang F, Vannucci SJ, Philp NJ, Simpson IA. Monocarboxylate transporter expression in the spontaneous hypertensive rat: effect of stroke. J Neurosci Res 79: 139–145, 2005.[CrossRef][ISI][Medline]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/6/E1607    most recent
00512.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Puchowicz, M. A.
Right arrow Articles by LaManna, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Puchowicz, M. A.
Right arrow Articles by LaManna, J. C.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.